Ares Capital Corporation (NASDAQ:ARCC) announced today that its CEO,
Kipp deVeer, is scheduled to present at the JMP Securities Financial
Services and Real Estate Conference on Tuesday, September 30, 2014 at
8:30 am EDT in New York City.
Baxter International Inc. (NYSE:BAX) and Merrimack Pharmaceuticals, Inc.
(Nasdaq:MACK) today jointly announced an exclusive license and
collaboration agreement for the development and commercialization of
MM-398 (nanoliposomal irinotecan injection), also known as ''nal-IRI.''
Through the agreement, Baxter gains exclusive commercialization rights
for all potential indications of MM-398 outside the United States and
Taiwan, and Merrimack retains commercialization rights in the United
States; the rights in Taiwan are held separately.
Seventh paragraph, first sentence of release should read: “Nearly 7
billion pieces of mail go undelivered every year due to bad addresses,”
said Patrick Brand, president of Pitney Bowes Mailing, North America
(instead of 7 million).
The corrected release reads:.
PITNEY BOWES HELPS MAILERS SUCCESSFULLY INTEGRATE PHYSICAL AND
DIGITAL COMMUNICATIONS AT GRAPH EXPO 14
Deutsche Asset & Wealth Management (Deutsche AWM) today announced its
non-traded, daily-valued real estate investment trust, RREEF Property
Trust, Inc. (RPT) has been granted NASDAQ ticker symbols “ZRPTAX” and
“ZRPTBX” for its Class A and Class B shares, respectively.
Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy
company primarily focused on developing first-in-class treatments for
rare and serious skin and connective tissue diseases, and Intrexon
Corporation (NYSE:XON), a leader in synthetic biology, today
announced plans to file an investigational new drug (IND) application
with the U.S. Food and Drug Administration (FDA) in the first half of
2015 for their drug candidate, GM-HDF-COL7 (genetically-modified human
dermal fibroblast, collagen VII). The companies are developing this new
cell-based therapeutic for the treatment of recessive dystrophic
epidermolysis bullosa (RDEB), the most severe form of the rare
connective tissue disorder epidermolysis bullosa.
MELBOURNE, AUSTRALIA --
One , a leader in providing financial services and data analytics to
more than 1,900 college and university campuses across the U.S., is
pleased to announce 21 recipients of its Financial
Literacy Counts grant program.
Insmed Incorporated (Nasdaq:INSM), announces that Company management
will participate in the upcoming Leerink Partners’ Rare Disease
Roundtable taking place October 1, 2014 at Le Parker Meridian Hotel in
New York City.
By Carla Mozee and Victor Reklaitis, MarketWatch
NEW YORK (MarketWatch) -- U.S. stocks rose Wednesday, as the S&P 500 recovered somewhat from a three-session losing streak that's been blamed in part on worries about global growth and Mideast fighting.
By John Revill
ZURICH--Mondelez International Inc. (MDLZ) and its Dutch coffee partner will focus on countries like Brazil and Russia as they look to grab market share from rivals in developed markets, according to the head of the food and beverage multinational's European coffee business.
Nate’s Foods Co, Inc. (OTC: CRRA) announced that it has received
approval today from the Financial
Industry Regulatory Authority ("FINRA") for a change in the name of
the Company effective September 25, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.